- 219
Australian-developed sleep technology exploring new, non-invasive approaches to sleep and human wellbeing.
GBLbiotech is an Australian sleep-technology company developing wearable technologies based around photobiomodulation, human-centred design and scientific investigation.
Building on more than 25 years of founder experience in the sleep and snoring industry, we are working to take original ideas from concept through research, product development and global commercialisation.
GBLbiotech Founder & CEO John Woodley has worked within the sleep and snoring industry since 1999.
From developing and commercialising his first snoring product through pharmacies and international markets to creating a new generation of wearable light-based technology, that experience has shaped the way GBLbiotech approaches innovation today.
We believe technology should not only be innovative.
.
Exploring how specific wavelengths of light can be incorporated into wearable technologies designed around biological processes.
Developing technology around one of the most important foundations of human health and wellbeing — sleep.
Creating small, non-invasive technologies intended to integrate more naturally into everyday life.
Taking emerging concepts through structured scientific, engineering, clinical and regulatory development where appropriate.
Silent Light™ represents GBLbiotech’s first commercial sleep-wellness platform.
Australian developed and designed as a small, non-invasive wearable, Silent Light™ reflects a core principle behind GBLbiotech:
Make technology simpler, more comfortable and easier to use.
Silent Light™ has its own dedicated consumer website for product information, purchasing, instructions and customer support.
Developing Silent Light™ has led me to think much bigger about where this technology could go.
After more than 25 years working in the sleep and snoring space, I’ve learned that meaningful innovation starts with asking the right questions — and then being prepared to test them properly.
At GBLbiotech, we are now exploring the next generation of wearable photobiomodulation and investigating how light may interact with peripheral biological pathways and physiological processes relevant to sleep.
This work is still firmly in the research and development stage.
My approach is simple: understand the science first, build the evidence, and then determine whether the findings justify progression into formal clinical research and medical-device development.
There is still a great deal to learn, but I believe it is a research direction worth pursuing.
John Woodley
Founder & CEO
GBLbiotech
Great Innovation Rarely Happens Alone
GBLbiotech welcomes conversations with organisations interested in helping advance new approaches to sleep technology.
We are particularly interested in connecting with:
Universities and research institutions
Sleep and respiratory researchers
Clinical research organisations
Medical-device specialists
Strategic healthcare companies
International commercial partners
Investors and licensing partners
